Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab

Clin Microbiol Infect. 2022 Sep;28(9):1297-1299. doi: 10.1016/j.cmi.2022.05.002. Epub 2022 May 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • COVID-19 Drug Treatment*
  • Humans
  • Mutation
  • SARS-CoV-2* / genetics

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • sotrovimab

Supplementary concepts

  • SARS-CoV-2 variants